NIH-funded research R01 grant

Longitudinal brain imaging in a form of speech-language degeneration (nfvPPA)

Official title: Longitudinal multi-modality imaging in non-fluent/agrammatic primary progressive aphasia

Funded at Mayo Clinic Rochester · NIH-11350994 · Data updated 2026-11-12

A Mayo Clinic study follows people with non-fluent/agrammatic primary progressive aphasia over time to map brain changes using advanced imaging and blood biomarkers.

More Aphasia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startJuly 1, 2013
Project endJune 30, 2028
Funding year2026
Award (this year)$684,052
NIH project number5R01DC012519-14
Project IDNIH-11350994 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are adults diagnosed with the non-fluent/agrammatic variant of primary progressive aphasia who can undergo PET imaging and blood tests.

Less likely to help

People who do not have nfvPPA or cannot participate in imaging or blood tests may not benefit.

What this research studies

This project tracks how brain structure and function change in people with non-fluent/agrammatic primary progressive aphasia (nfvPPA) using multiple imaging methods and blood tests. Researchers will use PET imaging to measure brain inflammation and analyze blood-based biomarkers like neurofilament light chain and GFAP to understand disease biology. The study aims to see how these biological signals relate to how the disease progresses and to clinical symptoms such as speech and language difficulties. By following participants over several years, the team hopes to identify markers that reflect disease activity and could guide future treatments.

Why it matters

Potential benefit: If successful, the work could help doctors monitor disease progression more accurately and pave the way for targeted therapies for nfvPPA.

How similar studies have gone: Previous cycles showed imaging and biomarkers can reveal disease patterns, supporting the potential value of these approaches in nfvPPA.

Where this research is happening

  • Mayo Clinic Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Whitwell, Jennifer Louise — Mayo Clinic Rochester
  • Study coordinator: Whitwell, Jennifer Louise

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.